These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3104537)

  • 1. The influence of acute and subchronic administration of various antidepressants on early morning melatonin plasma levels in healthy subjects: increases following fluvoxamine.
    Demisch K; Demisch L; Nickelsen T; Rieth R
    J Neural Transm; 1987; 68(3-4):257-70. PubMed ID: 3104537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human plasma melatonin is elevated during treatment with the monoamine oxidase inhibitors clorgyline and tranylcypromine but not deprenyl.
    Murphy DL; Tamarkin L; Sunderland T; Garrick NA; Cohen RM
    Psychiatry Res; 1986 Feb; 17(2):119-27. PubMed ID: 3008207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the effects of acute fluvoxamine and desipramine administration on melatonin and cortisol production in humans.
    Skene DJ; Bojkowski CJ; Arendt J
    Br J Clin Pharmacol; 1994 Feb; 37(2):181-6. PubMed ID: 8186063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin function in panic disorder: a double blind placebo controlled study with fluvoxamine and ritanserin.
    Den Boer JA; Westenberg HG
    Psychopharmacology (Berl); 1990; 102(1):85-94. PubMed ID: 1697419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug plasma levels and platelet 5-HT uptake inhibition during long-term treatment with fluvoxamine or lithium in patients with affective disorders.
    Wood K; Swade C; Abou-Saleh M; Milln P; Coppen A
    Br J Clin Pharmacol; 1983; 15 Suppl 3(Suppl 3):365S-368S. PubMed ID: 6407498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clovoxamine and fluvoxamine-2 biogenic amine re-uptake inhibiting antidepressants: quantitative EEG, psychometric and pharmacokinetic studies in man.
    Saletu B; Grünberger J; Rajna P; Karobath M
    J Neural Transm; 1980; 49(1-2):63-86. PubMed ID: 6777458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melatonin and cortisol increase after fluvoxamine.
    Demisch K; Demisch L; Bochnik HJ; Nickelsen T; Althoff PH; Schöffling K; Rieth R
    Br J Clin Pharmacol; 1986 Nov; 22(5):620-2. PubMed ID: 3098271
    [No Abstract]   [Full Text] [Related]  

  • 8. The psychopharmacological effects of repeated doses of fluvoxamine, mianserin and placebo in healthy human subjects.
    Curran HV; Lader M
    Eur J Clin Pharmacol; 1986; 29(5):601-7. PubMed ID: 3082644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of co-administration of antidepressants and monoamine oxidase inhibitors on 5-HT-related behavior in rats.
    Izumi T; Iwamoto N; Kitaichi Y; Kato A; Inoue T; Koyama T
    Eur J Pharmacol; 2007 Jun; 565(1-3):105-12. PubMed ID: 17400208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical use of the determination of serotonin in whole blood.
    Kremer HP; Goekoop JG; Van Kempen GM
    J Clin Psychopharmacol; 1990 Apr; 10(2):83-7. PubMed ID: 2111336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronopharmacological study of antidepressants in forced swimming test of mice.
    Ushijima K; Sakaguchi H; Sato Y; To H; Koyanagi S; Higuchi S; Ohdo S
    J Pharmacol Exp Ther; 2005 Nov; 315(2):764-70. PubMed ID: 16079297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of antidepressants and other psychotropic drugs on melatonin release and pineal gland function.
    Murphy DL; Garrick NA; Tamarkin L; Taylor PL; Markey SP
    J Neural Transm Suppl; 1986; 21():291-309. PubMed ID: 2875125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tranylcypromine lowers human platelet MAO B activity but not concentration.
    Fritz RR; Malek-Ahmadi P; Rose RM; Denney RM; Abell CW
    Biol Psychiatry; 1983 Jun; 18(6):685-94. PubMed ID: 6871302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of repeated doses of fluvoxamine, mianserin and placebo on memory and measures of sedation.
    Curran HV; Shine P; Lader M
    Psychopharmacology (Berl); 1986; 89(3):360-3. PubMed ID: 3088664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluvoxamine, a specific 5-hydroxytryptamine uptake inhibitor.
    Claassen V; Davies JE; Hertting G; Placheta P
    Br J Pharmacol; 1977 Aug; 60(4):505-16. PubMed ID: 302726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of co-administration of subchronic lithium pretreatment and acute MAO inhibitors on extracellular monoamine levels and the expression of contextual conditioned fear in rats.
    Kitaichi Y; Inoue T; Nakagawa S; Izumi T; Koyama T
    Eur J Pharmacol; 2006 Feb; 532(3):236-45. PubMed ID: 16487506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of antidepressant treatment on platelet 5-HT content and relation to therapeutic outcome in unipolar depressive patients.
    Mück-Seler D; Jakovljević M; Deanović Z
    J Affect Disord; 1991 Nov; 23(3):157-64. PubMed ID: 1774431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of pharmacologically selective antidepressants on serotonin uptake in rat platelets.
    Fisar Z; Anders M; Kalisová L
    Gen Physiol Biophys; 2005 Mar; 24(1):113-28. PubMed ID: 15900091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A preliminary study of fluvoxamine maleate on depressive state and serum melatonin levels in patients after cerebral infarction.
    Sunami E; Usuda K; Nishiyama Y; Otori T; Katsura K; Katayama Y
    Intern Med; 2012; 51(10):1187-93. PubMed ID: 22687788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of brofaromine and pargyline on human plasma melatonin concentrations.
    Bieck PR; Antonin KH; Balon R; Oxenkrug G
    Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12(1):93-101. PubMed ID: 3363166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.